Drug survival of biologics in treating psoriasis: a meta-analysis of real-world evidence
出版年份 2018 全文链接
标题
Drug survival of biologics in treating psoriasis: a meta-analysis of real-world evidence
作者
关键词
-
出版物
Scientific Reports
Volume 8, Issue 1, Pages -
出版商
Springer Nature America, Inc
发表日期
2018-10-24
DOI
10.1038/s41598-018-34293-y
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Etanercept, adalimumab, and ustekinumab in psoriasis: analysis of 209 treatment series in Austria
- (2017) Leo Richter et al. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT
- Long-term drug survival and predictor analysis of the whole psoriatic patient population on biological therapy in Hungary
- (2017) Lilla Pogácsás et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Drug survival of biologic treatments in psoriasis: a systematic review
- (2017) Daniel J. No et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Drug survival in psoriatic patients treated with biologic agent for the first time
- (2017) JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Biologic drug survival in Israeli psoriasis patients
- (2017) Guy Shalom et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Risk of Uveitis Among People With Psoriasis
- (2017) Ching-Chi Chi et al. JAMA Ophthalmology
- Survival and Effectiveness of Tumour Necrosis Factor-alpha Inhibitors in the Treatment of Plaque Psoriasis under Daily Life Conditions: Report from the Psoriasis Registry Austria
- (2016) M Inzinger et al. ACTA DERMATO-VENEREOLOGICA
- Survival rates of biological therapies for psoriasis treatment in real-world clinical practice: A Canadian multicentre retrospective study
- (2016) Joseph EC Marinas et al. AUSTRALASIAN JOURNAL OF DERMATOLOGY
- Body mass index predicts discontinuation due to ineffectiveness and female sex predicts discontinuation due to side-effects in patients with psoriasis treated with adalimumab, etanercept or ustekinumab in daily practice: a prospective, comparative, long-t
- (2016) J. Zweegers et al. BRITISH JOURNAL OF DERMATOLOGY
- Drug survival rates and reasons for drug discontinuation in psoriasis
- (2016) Tobias Arnold et al. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT
- ORBIT (Outcome and Retention Rate of Biologic Treatments for Psoriasis): A retrospective observational study on biologic drug survival in daily practice
- (2016) Eva Vilarrasa et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Adalimumab drug survival in patients with psoriasis, Crohn's disease, and rheumatoid arthritis: Relevant differences using the same treatment
- (2016) Juul M.P.A. van den Reek et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Biologic therapy adherence, discontinuation, switching, and restarting among patients with psoriasis in the US Medicare population
- (2016) Jalpa A. Doshi et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Drug survival of biologic therapy in a large, disease-based registry of patients with psoriasis: results from the Psoriasis Longitudinal Assessment and Registry (PSOLAR)
- (2016) A. Menter et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Biological therapies for psoriasis: Adherence and outcome analysis from a clinical perspective
- (2015) Christopher Ross et al. AUSTRALASIAN JOURNAL OF DERMATOLOGY
- Comorbidity as a predictor for drug survival of biologic therapy in patients with psoriasis
- (2015) Arnd Jacobi et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Healing Refractory Venous Ulcers: New Treatments Offer Hope
- (2015) Robert S. Kirsner et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Differential Drug Survival of Biologic Therapies for the Treatment of Psoriasis: A Prospective Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)
- (2015) Richard B. Warren et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- OBSERVE-5: Observational postmarketing safety surveillance registry of etanercept for the treatment of psoriasis final 5-year results
- (2015) Alexa B. Kimball et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- British Society for Cutaneous Allergy
- (2014) BRITISH JOURNAL OF DERMATOLOGY
- ‘Happy’ drug survival of adalimumab, etanercept and ustekinumab in psoriasis in daily practice care: results from the BioCAPTURE network
- (2014) J.M.P.A. van den Reek et al. BRITISH JOURNAL OF DERMATOLOGY
- Drug survival is not significantly different between biologics in patients with psoriasis vulgaris: a single-centre database analysis
- (2014) S.P. Menting et al. BRITISH JOURNAL OF DERMATOLOGY
- Comparison of long-term drug survival and safety of biologic agents in patients with psoriasis vulgaris
- (2014) R. Gniadecki et al. BRITISH JOURNAL OF DERMATOLOGY
- Cost-efficacy of biologic therapies for moderate to severe psoriasis from the perspective of the Taiwanese healthcare system
- (2014) Shu-Hui Wang et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Predictors of adalimumab drug survival in psoriasis differ by reason for discontinuation: long-term results from the Bio-CAPTURE registry
- (2014) J.M.P.A. van den Reek et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Drug Survival Rates And Cost of Biological Agents for the Treatment of Moderate to Severe Psoriasis in the Balearic Islands (Spain)
- (2014) P. Ventayol VALUE IN HEALTH
- Efficacy and Cost-Efficacy of Biologic Therapies for Moderate to Severe Psoriasis: A Meta-Analysis and Cost-Efficacy Analysis Using the Intention-to-Treat Principle
- (2014) Ching-Chi Chi et al. Biomed Research International
- Survival rate of antitumour necrosis factor-α treatments for psoriasis in routine dermatological practice: a multicentre observational study
- (2013) M. Esposito et al. BRITISH JOURNAL OF DERMATOLOGY
- Adalimumab for the treatment of psoriasis in real life: a retrospective cohort of 119 patients at a single Spanish centre
- (2013) A. López-Ferrer et al. BRITISH JOURNAL OF DERMATOLOGY
- Determinants of drug survival for etanercept in a long-term daily practice cohort of patients with psoriasis
- (2013) J.M.P.A. van den Reek et al. BRITISH JOURNAL OF DERMATOLOGY
- Treatment patterns with etanercept and adalimumab for psoriatic diseases in a real-world setting
- (2013) Machaon Bonafede et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Drug survival rates in patients with psoriasis after treatment with biologics
- (2013) Yoshinori Umezawa et al. JOURNAL OF DERMATOLOGY
- Long-term study of infliximab for psoriasis in daily practice: drug survival depends on combined treatment, obesity and infusion reactions
- (2013) J. Spertino et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Drug survival rates of biologic treatments in patients with psoriasis vulgaris
- (2011) A.M.G. Brunasso et al. BRITISH JOURNAL OF DERMATOLOGY
- Comparison of drug survival rates for adalimumab, etanercept and infliximab in patients with psoriasis vulgaris
- (2011) R. Gniadecki et al. BRITISH JOURNAL OF DERMATOLOGY
- Impact of body mass index on retention rates of anti-TNF-alfa drugs in daily practice for psoriasis
- (2011) Vito Di Lernia et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- A Novel Composite Endpoint to Evaluate the Gastrointestinal (GI) Effects of Nonsteroidal Antiinflammatory Drugs Through the Entire GI Tract
- (2009) F. K. L. CHAN et al. JOURNAL OF RHEUMATOLOGY
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More